Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 165.89
-2.05 %
$ 74.8 B
Market Cap
31.18
P/E
ZTS - COST OF REVENUE
Cost of Revenue ZTS - Zoetis Inc.
2.71 B
LAST VALUE
8.48%
2 YEAR CAGR
7.24%
5 YEAR CAGR
4.97%
10 YEAR CAGR